Vffiaqffi?Qiardffiri+Wtq Frfuil-Q-+. Ewft Qwffirr Onfu Qdtrn Dffu Qiqr Qr Atqfdqtqr*A Ffwn )Qdfud\T I+Qw Dt7wqr Gadr Aaw6 Qffiatar Mq Qmdt Gdgqnr T Dar Ilv Dfu
Total Page:16
File Type:pdf, Size:1020Kb
m.fu.m./* en /*tfus- q qisTfr/e o/q o q q iwerf lr*rn u,T qicrq, gui fui-*^ Xo/oq/qoq1 qfrErm fqqq :- tqtfi$qh- i+wrqT qreqqrcffi. xiel :- q) qr. eirTm, Gl=r q e\qE q{rml-{ fi q-fiqrs-er.m.o}f+st-7ffiq Ef,qqm71o1-tq, kqis q/xho lt. qI m-rqlmqrs-*m qr mrqffio BrT*gl^ m. fq.qr. /en.q /mrfu /qsq q'frqi*. q\ixlRo?q. *ffieqq'rqffio 3lTkrm. fq.*.r. /en.q ffi /qrgr ffi .fr{i6 tq/x/?oRq. 6i,.irfl*-a&lf,".* Br=I qiffiiT rrr +r.etlWi tt.eTr-{ffi, E stqE v{TRFI F. .No. Remdesivir tLZ 47 2t/ 0B tfliq. qi/x/Ro?q €IrE kqt*. Qo/oq/QoQ{ ffi g't lW qril fld-eT q11q Hfir*{ E++qrq e +{ qTzqr€rat BqtreT ewd-€r q11 ffi{ E+flH erqn qsq lotQl HfiH-+{ Effi srunfiq qrqlmTui fr65q qre FtEd-qT *-grqrf, Gilffi eTrt H{t {ciftrf, s}ks s,.qeqiqt Hi+ =ndTqEk qqtkuqTd 3rT-+eT ffi E stqq Twdrqr I+m .ut+*Eq f,rFfl-a iqtFr*{ ii+wH yrFF{fi q-sq qrfl-qf, fn+f, ++eT q{ri ma q-}6 . qffi} srq q?iqm qlE1ffi qsR+ fti'nt , zrarem, eq{ EtqT{ Tdr qT-+ Rtdr Frurcrq qflRl-{ E qrss-fu+fr qi-fi irt+ qTt {cifrId ++s Frundqifr sfl"fi 3fiqq q6 qTH sF=T nnffi glqrtrqr€qr +c{ ts q{ s61 ffi mftrq;Rq{ q HftrFd qffiti oU ertreq* qrs.h- ffi qrcr *-{0} s+rw+o ent qrqwirqt EkRcIfi sF=T qrsEr-ffiE1 eiqt{r+ g+q kil{q vqr sTrffi frrtffiq g+fro e vtrqqlq / qlsfr ErTd strt-i eTrt trqd Er*f, ewfr flq Frqvlfl€ 3Trmt eTrt 6\,61fua6qda Fluti+ iM*. ot+ tq3ffir t++flr fufwqn ttd +i. Hr{* Frurii Effid qftihr srrqr ffis qi{r iqmre- iiqwm erT.T'+tqrat rr6EF srr{Trnd *-{rS iild. qnf,ko qEdT vrrsiTE,stiT orTtytrgaTi ft{iq. ql qlqd RoRt qrq{ tq}firffr- iiq-qqi f{ilrq +-{dffimrfr eto orq{ iqtfirfr{ qiwr p}c FrurmqiqFq tskrer msq fuqrd nd sG. tqgfirfr ii+wm wr* i**-w {e} 3q6q ilEt q1tr Frqii ffiq. qiqr Wfirfr{ g+"flT frfu,qlq tttir +d qnd5t {rfl ii+flmqT orarqr-qnatutq qrFr;TT fu-dd erqdt ffi{rq +f, eTrt Vffiaqffi?qiardffiri+wtq frfuil-q-+. ewft qwffirr onfu qdTrn dffu qiqr qr atqfdqTqr*a Ffwn )qdfud\T i+qw dt7wqr gadr aaw6 qffiatar Mq qMdT gdgqnr t dar ilv dfu. trqd Erqd €tsd qls+eT yqr or n eTrfrr q. qfim fuer ar*m qtffi R-qr qrH,*. Sr+r qr Covid-q,q qI tqr;zqr dqqrtr+d}teT;eqT q?t'd riti{ fu-qr{rd A-$ ffi-t+*flTqr qFl-{cF-{u?il-f, qql. qif+s-tq, a$T+. HTrftqd q.rq *-{unt ffir q{d sqr: qdrq *qr, {6mq{qrftffi'r, etrtqrkor, qtfr{T, rr6qiT, UrqF{flq, qrl1|dfiH, sl=t E[ 3i]qq qsns{, qfr€{ Ef,rfr Pd|dq onertmiqT orfln rft q 6ffi qiffi to rd-+a {r*d iffir+ t{+sr rrr. qrgffi, q=t a sflqq lrrns{ t*qp 6 H ergqd riaflerd *-iTrgT +{dqr Hfirft ,r*,rqr+ trqm qr}. gul qETrruwfd-sl, tpt :rorrRqTk*.r,gr) grq"ft qfrqq,gut 'rTfroT, q,I{qrksr qyfl-{Fr E ;IrT{ riqTTf,€a BrTTfi ertqq e qflrs{ , gu} vrer+a {tiftrd sIR}q ffi-n q'AFrf-fr ertltrq elfrrfirt qict R-fl fud{uT HffiEqR qrzq eto Br-sfrqi q q{{ ffid q\qtf-qT Bfdfr frft+T Etd Br€@T* Aatffi qkrcEqT o-s-+ erFrkror or-6aca{Rr liciRmiil{ sn-drt ftar*. Tiqfiiq eTlkrifl-f, s.r q*'m wnt q?Tfiiqt ercq dfiqr{qr qr& q fqft+rrqwd qkrqqr eisT gTffiffir oiTd-d-+q {Eiftrf, Frqrtrq qflrsq / qr$s-ffi qi+fi fuqrTsrc q,rrql-t s.sr 3l6qrr qrqT s{rqr. qq{qt tq}nrff{ ii+*{Frt Frq?r.r frorq el-eq H{+d eTrffi qr+ qrrfui{flA ffir*'rft s.|qiffi gt qr https:l/pune.gov.in/corona-virus-updates/. rlr {#o erar* BwreT ${dm qTffi srTt /-\-. ftr€dlr*rfl, g't -, itelt fw€r €[M* atzrplTtt=t rlrftiq.{trr, gutmfrdr tr*, Ft{dtfil Annexure - A E qrn RgsponglhE* ??J*$1rnalrll'*,oChgin L,r q{,.*r r ! €r., E i1 ,.i .-, r @ -?---&& e**-ffiee&ffi?&&ffi# *&^ - w&!4 & r,effi g es# It:, t.l \ i .: ,| d" t ! ! . c i. AtrSSiUte IfifiEeAr$&s15 : ' ;..' .?' . '.. ,t:'-:r':' 1) L'lypoxemia requiriilg supplerfientaIoxygen ta maintain seturation abcve S2% and duration of illness <12 0ays t utusI . r *r 5?{1/e t R#lefrtion g: 1) HRTC ,core > 1CI with cytokine ffiarkers more than triple thr upper normal lin'rit. 2) Persistan(e of fever >100 F for 3 days with O2 :aluralion <92% 3) Associated c*morbidities like diabetir irctoacidosis, Cor pL:lmonale, orn immunosuppressive drugs and eviclence of hyporemia or X-ray Chest showing. evidcnce of pneum*nia. 4) Moderate or severe COVIf-19 di:ease of less than l0 days duration. d* r,r +r t- o e i e t r{ i q-rt i :, sx * r"* S €} x* **q s$ * a. ia.?i * \- ul ; L i !]'$ t ! I &,{.1 iL; {-r t i! } i,: } Fq tr I *. -d il }! U E t 1) All mild eares *f COVID-I$ di:ease. 2) Fati*nts with e ritical disease and m*lti-CIrgfin failure 3){OVID-19 disease of more than 14 elay: CLrraliorr *lnle*tiom ffiemdesiwir Sh*axt$ he used f*r m per;e$ *f S dcy* enly" Annexure - B Subject : - Treatment of Covid-l9 positive patient. It has been come to the notice that protocol circulated by Maharashtra Task Force is not being followed at all hospitals. Hence, following guidelines should be given to treating physicians 1. Single anti viral drug to be used at a time. If Remdisivir is being given, there is no need to continue favipiravir. 2. Once patient is Covid -19 positive, there is no role of Oseltamivir. 3. Those patients who have features of cardiac dysfunction should be monitored closely for left ventricular failure. Remdisivir should be used with caution in these patients. 4. If patient has bradycardia after Remdisivir , repeat dose should be monitored for cardiac dysfunction. If present, Remdisivir best be avoided. These patients should be evaluated with trop-t ,CPK-MB. 5. In patients with carditis, Dexamethasone should be preferred over methyl prednisolone. qtt-I - iF' *rytftr*{ €*ffitrqT qT'rq a $Y*:[:m msr{r ffiRfr'E B{tErLr i q+ks snwrwrd rrsrcrT$r .Tq-r{r Ent Brfr qTS, *lft:ger mm r1rgl1 ffi-qT qrrl;iqT q-{ t qi',q &k, q}.q grrTrrffir t"rryfr arr* Aqq gq-qlrft E13i sr*a. ffi gtl?rrprffifr qrffi rnwr S,fu-*t srl{rqr&e q&er* qtzq* *wrwrtt $r .grrffiq* oTffi qr+ E qrffitt* 6qq+ go ffi*rr "rfr srftffi. l&r 're1119 *ii! 6ryqoqrfr qFffirfiT tsrffffi rtil ,\1, ,'lJI t rm* fterttwT qr€r Bas rffq q6Tq F qrsr spo2 ) *'q tir (' r " "frfi ) * qtmir q q q&rr s,fr ET*. t) qffie :r* ;urq1fr-q'r E affim'rFnffi c,q ta{r 6* frte. t) gfr,qr s{ttrxrtrT qk.ar$ sie*nt er"r (a'gtx', arnr - {.) rd.n Fgxifrqr frqr erHrffr vr-d# qr terr qil* *fr. "q-ii-,T v)ernten qffilaTtrfr da-qr r+rq e" .rarr wrffi, etrrdrcr cytokine rylsyksps rrrit *;1.rc ET6 ;r spo2 r-R fudr 6* d"f , r{fu*tdtd{ qrffirhn rx$dfm ;rs{ S _k&( ts ?r*. r)wi?n qtks ?q &u qfgfi-e€ ar* q-{q ffii* tawo} ;rl-&{. q)fi'f dq sTrqT? artr'& sr*r ($ffi H-S/ qrTS*') E)€{fs at?rqq ffi&tT rEfrA ar"T (muki-orsandysfunction} v) to fre$iqq{r qr{n ftffir m'H& srqr# q.or t)ary* is*{frSr $ryES el-rr8* srq. trr Sryqtql rffir fu('srr ftrqrr qftwftfi-s xrurtrrr ffii{ "r$'€ ts}fr*T *$ Frq t )u-g'o G-d,rT €fir&rqT rsrsr q)ffi'fBqTq amrffi w"r a )-rcu fdfirr qu-e t'or fi*qr trMr*T ffi'ear *znri:ryr -Frqrq aH' q o i*rr *,* sntrd. DESIVIR ON 20-05-2021 PUNE - DISTRICT r PMc/PCMC/ FUNCTION DISTRIBUTOR Hospital NAME OF - COMPANY sR. AL BED IR Location NAME OF COVID HOSPITAL CANTONMENT/ DISTRIBUTOR MOBITE NO NO Contact No Dt toAl CAPACITY AttOTED TAL MDHAR HOSPITAL, PARGAON, L4 11 SURESH MEDICO NARAYANGAON 9t75956211 CIPLA 1 9975051000 AMBEGAON AMBEGAON KUNDAN 7887885017, AYURVEDIC HETERO BHIMASHANKAR AMBEGAON 90 72 WADKI 2 9890276968 PHARMACON 9822556263 HOSPITAL & RESEARCH CENTRE 10 ;URESH MEDICO NARAYANGAON 9175956231 CIPLA 3 CITY HOSPITAL MANCHAR 7447430043 AMBEGAON t2 /ARHADI PHARMA 38 30 NARAYANGAON 9970818185 CIPLA 4 GATEWELL HOSPITAL MANCHAR 9075742600 AMBEGAON 5 4 SURESH MEDICO NARAYANGAON 9175955231 CIPLA 5 GUJARATHI HOSPITAL, MANCHAR 8149674213 AMBEGAON CIPLA AMBEGAON 20 16 GANDHI MEDICO MANCHAR 8600015446 6 MATOSHREE HOSPITAL MANCHAR 9284968321 OM HOSPITAL PARGAON T. AVSARI 7 GANDHI MEDICO MANCHAR 8600015446 CIPLA 17 9975593724 AMBEGAON 9 's' BK \d' 7 5 GANDHI MEDICO MANCHAR 8600015446 CIPLA s POTANIS HOSPITAL GHODEGAON 9970208787 AMBEGAON s.Y inl.r SANJIVAN HOSPITAL GHODEGAON MEDICO MANCHAR 8600015446 CIPLA SJ Jg 9890207s03 AMBEGAON 15 t2 GANDHI *i ROAD MANCHAR PHARMA -,/* HOSPITAL VARHADI CIPLA ;HREE VINAYAK AMBEGAON t4 10 NARAYANGAON 9970818186 10 9850125517 AGENCY MANCHAR 6 5 ;URESH MEDICO NARAYANGAON 9175956231 CIPLA del 11 VARPE HOSPITAL MANCHAR 9960251560 AMBEGAON 14 10 SURESH MEDICO NARAYANGAON 9175956231 CIPLA 72 GAVDE HOSPITAL MANCHAR 8275464982 AMBEGAON 4 SAMARTH MEDICO MANCHAR 9423508650 HETERO 13 9766692444 AMBEGAON 5 GORKSHANATH TEKADI AWASARI MEDICO MANCHAR 9423508560 HETERO r+ lonaruoe HoSPITALALEPHATA 9890702824 JUNNAR t4 TL SAMARTH L4 ;AMARTH MEDICO MANCHAR 9423508660 HETERO 15 GLOBAL CCC NARAYANGAON 9860276043 JUNNAR 18 SAMARTH MEDICO MANCHAR 9423508550 HETERO 16 KHAIRE HOSPITAL, NARAYANGAON 9822331088 JUNNAR 20 16 N4AHESH MEMORIAL HOSPITAL 9552304597, MEDICO MANCHAR 9423508650 HETERO L7 JUNNAR 11 9 ;AMARTH RAJURI 98817L4374 MANISHA GRAMIN RUGNALAY 96s7002932, PHARMA MANCHAR 9890207503 HETERO 18 JUNNAR 25 20 PAREKH IUNNAR 7558585877 PHARMA MANCHAR 9890207503 HETERO 19 MAUL| ALEPHATA | 99109622s9 JUNNAR 15 12 PAREKH MAX CARE MULTISPECIALIW 9975242025, MANCHAR 9890207503 HETERO 20 JUNNAR 14 11 PAREKH PHARMA HOSPITAL NARAYANGAON 8971396063 CM CHAITANYA HOSPITAL 9860920989, HETERO 2t JUNNAR 20 15 PAREKH PHARMA MANCHAR 9890207503 ALEPHATA, JUNNAR 9422t67739 PHULAVADE HOSPITAL PHARMA MANCHAR 9890207503 HETERO 22 7822525269 JUNNAR 10 8 PAREKH NARAYANGAON )ISE HOSPITAL ALEPHATA TULSI MANCHAR 9890207503 HETERO 23 9130789536 ]UNNAR 10 8 PAREKH PHARMA sHALAKWADI SAI GULAB HOSPITAL JUNNAR 9890207503 HETERO 24 9970745185 JUNNAR 25 20 ?AREKH PHARMA MANCHAR SANCHALIT DCHC LEYNADRI PHARMA MANCHAR 9890207503 HETERO 25 SHIVNERI HOSPITAL, JUNNAR 9960037604 JUNNAR 10 8 PAREKH SPANDAN HOSPITAL, ALEPHAT& 9890207503 HETERO 26 9960980990 JUNNAR 15 t2 PAREKH PHARMA MANCHAR JUNNAR SWAMI VIVEKANAND HOSPITAL 9860240972, MANCHAR 9423508560 HETERO 27 JUNNAR 40 32 SAMARTH MEDICO NARAYANGAON